Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (131-140 of 237) with videos related to

Pageof 24
Sort By:
Neurotoxicology and Teratology|May 4, 2021
A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801Patrick J Morris, Richard D Burke, Alok K Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2011
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinaseMartin J Walsh, Kyle R Brimacombe, Henrike Veith, et al.
Scientific Reports|November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination ScreeningLu Chen, Kelli Wilson, Ian Goldlust, et al.
Science (New York, N.Y.)|November 5, 2011
Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responsesDimitrios Anastasiou, George Poulogiannis, John M Asara, et al.
SLAS Technology|October 6, 2018
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug EfficacyKelli M Wilson, Lesley A Mathews-Griner, Tara Williamson, et al.
Journal of the American Chemical Society|October 5, 2018
Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase InhibitorsSara E S Martin, Zhi-Wei Tan, Harri M Itkonen, et al.
Science Translational Medicine|March 17, 2012
Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDASJieqing Zhu, Won-Seok Choi, Joshua G McCoy, et al.
Medchemcomm|December 4, 2012
A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases()Bryan T Mott, Ken Chih-Chien Cheng, Rajarshi Guha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2009
Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and miceSusanne Neumann, Wenwei Huang, Steve Titus, et al.
JCI Insight|March 8, 2023
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancerAnju Kumari, Lisa Gesumaria, Yan-Jin Liu, et al.
Pageof 24

Showing results (131-140 of 237) with videos related to

Sort By:
Pageof 24
Neurotoxicology and Teratology|May 4, 2021
A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801Patrick J Morris, Richard D Burke, Alok K Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2011
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinaseMartin J Walsh, Kyle R Brimacombe, Henrike Veith, et al.
Scientific Reports|November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination ScreeningLu Chen, Kelli Wilson, Ian Goldlust, et al.
Science (New York, N.Y.)|November 5, 2011
Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responsesDimitrios Anastasiou, George Poulogiannis, John M Asara, et al.
SLAS Technology|October 6, 2018
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug EfficacyKelli M Wilson, Lesley A Mathews-Griner, Tara Williamson, et al.
Journal of the American Chemical Society|October 5, 2018
Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase InhibitorsSara E S Martin, Zhi-Wei Tan, Harri M Itkonen, et al.
Science Translational Medicine|March 17, 2012
Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDASJieqing Zhu, Won-Seok Choi, Joshua G McCoy, et al.
Medchemcomm|December 4, 2012
A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases()Bryan T Mott, Ken Chih-Chien Cheng, Rajarshi Guha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2009
Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and miceSusanne Neumann, Wenwei Huang, Steve Titus, et al.
JCI Insight|March 8, 2023
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancerAnju Kumari, Lisa Gesumaria, Yan-Jin Liu, et al.
Pageof 24